We are live on ! Find out more
FANJ

Financial Architects (New Jersey) Portfolio holdings

AUM $663M
1-Year Est. Return 15.53%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+15.53%
3 Year Est. Return
+31.35%
5 Year Est. Return
+47.6%
10 Year Est. Return
+147.74%
AUM
$564M
AUM Growth
+$138M
Cap. Flow
+$97.3M
Cap. Flow %
17.25%
Top 10 Hldgs %
28.63%
Holding
1,695
New
281
Increased
408
Reduced
360
Closed
97

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.1%
2 Financials 18.38%
3 Healthcare 5.24%
4 Technology 5.21%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SE
1676
DELISTED
Spectra Energy Corp Wi
SE
-2,732
Closed -$112K
CPPL
1677
DELISTED
Columbia Pipeline Partners LP
CPPL
-706
Closed -$12K
ARIA
1678
DELISTED
Ariad Pharmaceuticals Inc
ARIA
-600
Closed -$7K
TMH
1679
DELISTED
Team Health Holdings Inc
TMH
-100
Closed -$4K
APOL
1680
DELISTED
Apollo Education Group Inc Class A
APOL
-1,100
Closed -$11K
STJ
1681
DELISTED
St Jude Medical
STJ
-500
Closed -$40K
DRYS
1682
DELISTED
DryShips Inc. Common Stock
DRYS
0
CELGZ
1683
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$0 ﹤0.01%
450
VISN
1684
DELISTED
VisionChina Media, Inc.
VISN
-300
Closed -$1K
CTIC
1685
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$0 ﹤0.01%
+10
New +$46
CYTR
1686
DELISTED
CytRx Corp
CYTR
$0 ﹤0.01%
133
PGH
1687
DELISTED
Pengrowth Energy Corporation
PGH
$0 ﹤0.01%
150
RIBT
1688
DELISTED
RiceBran Technologies
RIBT
$0 ﹤0.01%
14
AST
1689
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$0 ﹤0.01%
120
IMUC
1690
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$0 ﹤0.01%
1
XIV
1691
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
-1,000
Closed -$46K
BCS.PRA.CL
1692
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
-16,600
Closed -$421K
HAWK
1693
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$0 ﹤0.01%
10
RHT
1694
DELISTED
Red Hat Inc
RHT
-500
Closed -$35K
MHG
1695
DELISTED
Marine Harvest ASA
MHG
-850
Closed -$15K

Similar funds

Financial Architects (New Jersey)'s Q1 2017 Portfolio in Review

As of Q1 2017, Financial Architects (New Jersey) held 1,695 positions worth $564M, up 33% from $426M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Financial Architects (New Jersey) deployed $97.3M of net new capital in Q1 2017, opening 281 new positions and adding to 408 existing holdings. Its largest new stake was Franklin Templeton: 8,290 shares worth $349K.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 55% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.7M trimmed.

  • Financial Architects (New Jersey)'s largest Q1 2017 buy was Franklin Templeton: 8,290 shares worth $349K.
  • Financial Architects (New Jersey) added most to Berkshire Hathaway Class B in Q1 2017, an estimated $36.7M increase.
  • Financial Architects (New Jersey)'s biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $1.7M.
  • Financial Architects (New Jersey) fully exited Barclays Bank Plc Series 3 in Q1 2017, selling an estimated $421K.
  • Financial Architects (New Jersey)'s ten largest holdings make up 29% of its $564M portfolio in Q1 2017.
  • Financial Architects (New Jersey) opened 281 new positions and closed 97 in Q1 2017.
  • Financial Architects (New Jersey)'s portfolio value rose 33% quarter-over-quarter to $564M.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2017, filed 26 Apr 2017.